Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion
Conditions: Pancreas Adenocarcinoma; Endoscopic Ultrasound; Digital Pathology Interventions: Procedure: Endoscopic ultrasound fine needle biopsy Sponsors: Campus Bio-Medico University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Stage II/III Colorectal Cancer Recurrence
Conditions: Colorectal Cancer; Colorectal Adenocarcinoma; Colorectal Cancer Stage II; Colorectal Cancer Stage III; Colorectal Cancer Recurrent Interventions: Other: CENSURE Sponsors: City of Hope Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Combining EPI-7386 w/ Enzalutamide & Androgen Deprivation Therapy for Newly Diagnosed Prostate Cancer
Conditions: Metastatic Hormone-sensitive Prostate Cancer (mHSPC); Prostate Cancer; Prostate Adenocarcinoma Interventions: Drug: EPI-7386; Drug: Enzalutamide; Drug: Androgen Deprivation Therapy (ADT) Sponsors: Pedro Barata, MD, MSc; ESSA Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
Conditions: Pancreatic Cyst Interventions: Diagnostic Test: 89Zr-DFO-HuMab-5B1 immunoPET; Diagnostic Test: HP MRI; Combination Product: Blood assay Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma
Conditions: Pancreatic Ductal Adenocarcinoma Sponsors: First Affiliated Hospital of Chongqing Medical University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Conditions: Ovarian Cancer; Non-small Cell Lung Cancer Interventions: Drug: TUB-040 Sponsors: Tubulis GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
Conditions: Melanoma; Head and Neck Squamous Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Colorectal Cancer; Solid Tumor Interventions: Drug: IPN01194; Drug: IPN01194 Sponsors: Ipsen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials
A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique
Conditions: Gastric Cancer; Adenocarcinoma of Esophagogastric Junction Interventions: Procedure: Performing totally laparoscopic proximal gastrectomy with esophagogastrostomy by fissure technique Sponsors: Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Bleeding After Robot-assisted Radical Prostatectomy: a Respective Study
Conditions: Prostate Cancer; Bleeding; Prostate Adenocarcinoma Interventions: Procedure: robot-assisted radical prostatectomy Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Conditions: Ovarian Carcinoma; Fallopian Tube Carcinoma; Peritoneal Carcinoma; Endometrial Cancer; Adenocarcinoma of Lung; Triple Negative Breast Cancer; Liposarcoma; Leiomyosarcoma; Mesothelioma, Malignant; Adenocarcinoma - Gastroesophageal Junction (GEJ); Adenocarcinoma of the Stomach; Melanoma, Malignant; Renal Cell Carcinoma Interventions: Biological: NM32-2668 Sponsors: Numab Therapeutics AG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.
Conditions: Leptomeningeal Metastasis Interventions: Drug: Pemetrexed Sponsors: Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
Conditions: Prostate Cancer; Prostate Adenocarcinoma; Prostate Neoplasm; Prostatic Neoplasm; Obesity Interventions: Other: observational study Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico; National Research Council Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
Conditions: Metastatic Colorectal Cancer; Pancreas Adenocarcinoma; Cholangiocarcinoma Interventions: Diagnostic Test: Multiplex PCR-test for circulating tumor DNA Sponsors: Oslo University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery
Conditions: Oesophageal Adenocarcinoma; Gastric Adenocarcinoma Interventions: Other: Biosample collection Sponsors: Imperial College London; Cancer Research UK Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway
Conditions: Advanced Solid Tumor; RAF Mutation; RAS Mutation; NF1 Mutation; Non-Small Cell Lung Cancer; Pancreatic Ductal Adenocarcinoma; Melanoma; BRAF Gene Mutation; CRAF Gene Mutation Interventions: Drug: DCC-3084 Sponsors: Deciphera Pharmaceuticals LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
